| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.18 | 0.006 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |